← Eichor
Study identifier: NCT07191223 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Evaluation of Knowledge on Tick-borne Encephalitis Virus (TBEV) Infection Among General Practitioners in France

Condition: Tick-borne Encephalitis, France  ·  Sponsor: University Hospital, Strasbourg, France

PhaseN/A
Planned participants100
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Tick-borne encephalitis is a relatively rare disease (approximately 35 cases diagnosed per year), but most cases (86%) are due to contamination in France via a tick bite. Of the 71 cases reported over two years (May 2021 to May 2023), 94% of patients were hospitalized. It is therefore important to consider and diagnose at the first signs to ensure appropriate follow-up and also to implement primary prevention in endemic/at-risk areas.

This description comes directly from the study's public registry record.

Talk to the study team

Yves HANSMANN, MD  ·  33 3 69 55 09 78  ·  yves.hansmann@chru-strasbourg.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Service des maladies infectieuses et tropicales - CHU de Strasbourg - FranceStrasbourg, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07191223